Egalet Corp (EGLT):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Egalet Corp (EGLT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7462
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Egalet Corp (Egalet) is a specialty pharmaceutical company that develops, manufactures and commercializes novel treatments for pain and other conditions. Its product portfolio includes OXAYDO (oxycodone HCl, USP) tablets CII for the management of acute and chronic moderate to severe pain; SPRIX (ketorolac tromethamine) nasal spray for short-term management of moderate to moderately severe pain; and and Arymo ER (morphine sulfate) extended-release tablets C-II for chronic pain. The company develops products based on its proprietary Guardian technology, a polymer matrix tablet technology. Egalet is also developing pipeline of products using its Guardian Technology. It operates research facility, pilot manufacturing and administrative facility in Denmark. Egalet is headquartered in Wayne, Pennsylvania, the US.

Egalet Corp (EGLT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Egalet Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Egalet Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Egalet Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Egalet Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Egalet Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Egalet Corp, Medical Equipment, Deal Details 10
Venture Financing 10
Egalet Secures Venture Funding 10
Equity Offering 11
Egalet to Raise USD8.5 Million in Public Offering of Shares 11
Egalet Plans to Raise upto USD16 Million in Public Offering of Shares 12
Egalet Raises USD86.3 Million in Public Offering of Shares 13
Egalet Completes IPO For US$58 Million 15
Egalet Completes Private Placement Of Shares For US$15 Million 17
Egalet Corp – Key Competitors 18
Egalet Corp – Key Employees 19
Egalet Corp – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Financial Announcements 21
Aug 08, 2018: Egalet reports second quarter 2018 financial results 21
May 08, 2018: Egalet Reports First Quarter 2018 Financial Results 22
Mar 12, 2018: Egalet Reports Fourth Quarter and Full Year 2017 Financial Results 23
May 10, 2017: Egalet Reports First Quarter 2017 Financial Results 24
Mar 09, 2017: Egalet Reports Fourth Quarter and Full Year 2016 Financial Results 26
Corporate Communications 27
Jun 07, 2018: Egalet Names John Varian Board Director 27
Apr 10, 2017: Egalet Announces Changes to Board of Directors 28
Other Significant Developments 29
Nov 20, 2017: Egalet Received a Grant from InnoBooster to Develop a Novel Application of Guardian Technology 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Egalet Corp, Medical Equipment, Key Facts, 2017 2
Egalet Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Egalet Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Egalet Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Egalet Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Egalet Corp, Deals By Market, 2012 to YTD 2018 8
Egalet Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Egalet Secures Venture Funding 10
Egalet to Raise USD8.5 Million in Public Offering of Shares 11
Egalet Plans to Raise upto USD16 Million in Public Offering of Shares 12
Egalet Raises USD86.3 Million in Public Offering of Shares 13
Egalet Completes IPO For US$58 Million 15
Egalet Completes Private Placement Of Shares For US$15 Million 17
Egalet Corp, Key Competitors 18
Egalet Corp, Key Employees 19
Egalet Corp, Other Locations 20
Egalet Corp, Subsidiaries 20

List of Figures
Egalet Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Egalet Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Egalet Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Egalet Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Egalet Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Egalet Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Egalet Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Egalet Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Egalet Corp (EGLT):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ixia (XXIA):企業の財務・戦略的SWOT分析
    Summary Ixia (Ixia), a subsidiary of Keysight Technologies Inc, is a technology company that offers test architecture solutions and services. The company's products potfolio include visibility, test, cloud, security, performance monitoring, and test hardware products. Its security products comprise …
  • IOI Corporation Berhad:企業の戦略・SWOT・財務情報
    IOI Corporation Berhad - Strategy, SWOT and Corporate Finance Report Summary IOI Corporation Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • AVT McCormick Ingredients Pvt. Ltd.:企業の戦略・SWOT・財務情報
    AVT McCormick Ingredients Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report Summary AVT McCormick Ingredients Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Abreos Biosciences Inc-医療機器分野:企業M&A・提携分析
    Summary Abreos Biosciences Inc (Abreos Biosciences) is a biotechnology company that develops laboratory-based and point-of-care (POC) tests for precision dosing of biologic drugs. The company’s technology platform veritope, allow monitoring of monoclonal antibody drug levels in blood (novel or biosi …
  • Chimei Innolux Corporation (3481):企業の財務・戦略的SWOT分析
    Chimei Innolux Corporation (3481) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Dance Biopharm Inc:医療機器:M&Aディール及び事業提携情報
    Summary Dance Biopharm Inc (Dance Biopharm), a subsidiary of Dance Biopharm Holdings Inc, formerly Dance Pharmaceuticals Inc, is a biotechnology company that develops inhaled insulin products to treat diabetes patients. The company provides product pipeline such as Dance-501, a pocket-sized inhaler …
  • Pacific Edge Ltd (PEB):企業の財務・戦略的SWOT分析
    Summary Pacific Edge Ltd (PEB) is a diagnostics company that develops, discovers, and commercializes diagnostic tests for the early detection and monitoring of cancer. It offers lead products such as Cxbladder, a non-invasive laboratory test for the detection of bladder cancer. It also develops Cxco …
  • Pegasystems Inc (PEGA):企業の財務・戦略的SWOT分析
    Pegasystems Inc (PEGA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • MetGen Oy-製薬・医療分野:企業M&A・提携分析
    Summary MetGen Oy (MetGen) is a manufacturer and distributor of enzymatic solutions. The company provides metzyme, an industrial and natural catalysts used for accelerating chemical reactions. Its enzymatic solutions find applications in various processes such as mechanical processes, lignocellulosi …
  • Ono Pharmaceutical Co Ltd (4528):医療機器:M&Aディール及び事業提携情報
    Summary Ono Pharmaceutical Co Ltd (Ono Pharmaceutical) is a focuses on the research, development, manufacture and sale of prescription pharmaceuticals and diagnostic reagents. Its product portfolio includes pharmaceuticals for the treatment of type II diabetes, overactive bladder, osteoporosis, Alzh …
  • Triglav Group:企業の戦略・SWOT・財務分析
    Triglav Group - Strategy, SWOT and Corporate Finance Report Summary Triglav Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Spire Inc (SR):石油・ガス:M&Aディール及び事業提携情報
    Summary Spire Inc (Spire), formerly Laclede Group, Inc., is a public utility, which carries out the sale, marketing and retail distribution of natural gas. It also markets natural gas and related activities on a non-regulated basis. The company also conducts transportation of liquid propane; real es …
  • Claire’s Stores, Inc.:企業の戦略・SWOT・財務情報
    Claire’s Stores, Inc. - Strategy, SWOT and Corporate Finance Report Summary Claire’s Stores, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • HOCHTIEF Aktiengesellschaft:企業のM&A・事業提携・投資動向
    HOCHTIEF Aktiengesellschaft - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's HOCHTIEF Aktiengesellschaft Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Harbin Electric International Co Ltd:企業の戦略的SWOT分析
    Harbin Electric International Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • TIVIT Terceirizacao de Tecnologia e Servicos SA:企業の戦略的SWOT分析
    TIVIT Terceirizacao de Tecnologia e Servicos SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competito …
  • Egdon Resources Plc (EDR):企業の財務・戦略的SWOT分析
    Summary Egdon Resources Plc (Egdon) is oil and gas company that offers exploration and production services. The company explores and develops petroleum and natural gas assets in East Midlands, North East England, North West England, and Southern England, the UK. Its project site includes Wressle, No …
  • Flatiron Health Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Flatiron Health Inc (Flatiron Health) a subsidiary of F. Hoffmann-La Roche Ltd, is a healthcare technology company which develops a learning healthcare system in oncology. The company offers a web-based business and clinical intelligence data platform that integrates and structures disparate …
  • Merck KGaA (MRK)-医療機器分野:企業M&A・提携分析
    Summary Merck KGaA (Merck), a subsidiary of E. Merck KG, is a pharmaceutical and chemical company. It discovers, develops and manufactures prescription drugs to treat cancer, multiple sclerosis, and infertility and over-the-counter products for colds and pain; and develops liquid crystal mixtures, O …
  • Parker Hannifin Corp (PH):医療機器:M&Aディール及び事業提携情報
    Summary Parker Hannifin Corp (Parker) is a manufacturer of motion and control technologies and systems. The company offers critical motion and control solutions, including fluid power systems, electromechanical controls and related components. Its products find use in various industries and applicat …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆